Catalyst Pharmaceuticals, Inc. - Common Stock — Liquidità (NASDAQ:CPRX) | MetaTrader

Apri il grafico completo Full chart

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Flusso di cassa derivante dalle attività operative 45.03 M60.37 M116.05 M143.6 M239.81 M208.67 M 208.21 M Flussi di cassa derivanti dalle attività di investimento -5.01 M-11.02 M9.21 M-293.5 M-556 K-58 K -85 K Liquidità derivante dalle attività di finanziamento 701.93 K-8.14 M1.69 M-10.86 M140.66 M-16.99 M -32.93 M Liquidità libera 45.03 M60.37 M116.05 M143.6 M239.81 M208.61 M 208.13 M

Notizie

Why Catalyst Pharmaceutical (CPRX) is a Top Momentum Stock for the Long-Term

Why Catalyst Pharmaceutical (CPRX) is a Top Value Stock for the Long-Term

CPRX or UTHR: Which Is the Better Value Stock Right Now?

Catalyst Pharmaceuticals Q1 Earnings Beat, Firdapse Revenues Rise Y/Y

Gli EPS di Catalyst Pharmaceuticals hanno battuto le aspettative per 0,06$, il fatturato supera le previsioni

Catalyst (CPRX) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Catalyst Pharmaceutical (CPRX) Surpasses Q1 Earnings and Revenue Estimates

Perrigo Q1 Earnings Surpass Estimates, Sales Miss, Both Fall Y/Y

UTHR Q1 Earnings Miss Estimates, Shares Jump on Strong Outlook

ACAD Q1 Earnings & Revenues Miss Estimates Despite Y/Y Sales Growth

Madrigal Q1 Earnings Beat, MASH Drug Sales Drive Top Line, Stock Up

RXRX Q1 Loss Narrower Than Expected, Revenues Decline Y/Y